Integrated assessment of non-invasive diagnostic tools for bladder cancer: a network meta-analysis [0.03%]
膀胱癌非侵入性诊断工具的综合评价：网络 meta 分析
Desheng Zhang,Bo Chen,Junjiang Ye et al.
Desheng Zhang et al.
Background: Bladder cancer is a common and recurrent urologic malignancy. Although cystoscopy remains the diagnostic gold standard, its invasiveness, high cost, and limited patient compliance restrict its routine applicat...
Immunohistochemical analysis of Enolase-1 sublocalization in benign and malignant breast tumors: potential implications for tumor progression and prognosis [0.03%]
良性与恶性乳腺肿瘤中烯醇化酶-1亚定位的免疫组化分析及其对肿瘤进展和预后的潜在影响
Laura de Souza Baracioli,Caroline Patini Rezende,Luadna Dos Santos E Silva et al.
Laura de Souza Baracioli et al.
Breast cancer is the second most common neoplasm in women and one of the main causes of premature mortality, with a high incidence before the age of seventy. Among its histological subtypes, invasive ductal carcinoma accounts for approximat...
PDE10A as a novel diagnostic and therapeutic target in cancer: insights and challenges [0.03%]
PDE10A作为癌症诊断和治疗的新靶点：见解与挑战
Sahar Ghoflchi,Ali Nakhaei,Farzaneh Abbasinezhad-Moud et al.
Sahar Ghoflchi et al.
Phosphodiesterase 10A (PDE10A) is a dual-substrate enzyme that hydrolyzes both cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), playing a critical role in regulating intracellular signaling pathways. While it...
BI-RADS application for breast cancer screening in primary healthcare settings: assessing protocol adherence and diagnostic validity [0.03%]
BI-RADS在基层乳腺癌筛查中的应用：评估方案依从性和诊断准确性
Xiang Li,Hong Wang,Hui-Fang Xu et al.
Xiang Li et al.
Background: The application performance of the Breast Imaging-Reporting and Data System (BI-RADS) in primary healthcare settings remains uncertain. The normativity of BI-RADS classification and the efficacy of breast canc...
Marked under-diagnosis of Lambert-Eaton myasthenic syndrome in small cell lung cancer: an analysis of real-world claims data [0.03%]
小细胞肺癌患者中Lambert-Eaton肌无力综合征的诊断不足：对真实世界保险数据的分析
Benjamin J Drapkin,David J Morrell,Regina Grebla et al.
Benjamin J Drapkin et al.
Background: Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune neurologic condition causing progressive muscle weakness that can occur as a paraneoplastic disorder, most commonly in patients with small cell lung ca...
Xue Wang,Xuefeng Sun,Yuanyu Wu et al.
Xue Wang et al.
Aim: To explore the relationship between gastric cancer and sarcopenia and review the underlying mechanisms. Method: A systematic searc...
Case Report: Malignant peripheral nerve sheath tumor of the kidney with a novel granular cell morphology [0.03%]
病例报告：具有新型颗粒细胞形态的肾脏恶性外周神经鞘瘤
Danli Ye,Guangning Yan,Wenzhi Cui et al.
Danli Ye et al.
Malignant peripheral nerve sheath tumors (MPNSTs) arising from the kidney are rare. The present report describes a renal MPNST of a 33-year-old man exhibiting novel morphological features. Histologically, the tumor was comprised of spindle ...
Case Report: Malignant peripheral nerve sheath tumor of the thoracic spine with postoperative recurrence and intracranial metastasis-a review of the literature [0.03%]
胸椎恶性外周神经鞘瘤一例并术后复发及颅内转移-文献复习
He-Lu Wang,Hong-Tao Zhang
He-Lu Wang
Malignant peripheral nerve sheath tumors (MPNSTs) are uncommon and biologically aggressive sarcomas. Although primary involvement of the thoracic spine is rare, the occurrence of intracranial metastasis typically indicates advanced-stage di...
Prolonged overall survival in a child with multimetastatic retinoblastoma treated with anti-GD2 monoclonal antibody dinutuximab beta: a case report [0.03%]
抗GD2单克隆抗体dinutuximab beta治疗多发转移性视网膜母细胞瘤的患儿获得长期总生存期：个案报告
Valentina Di Ruscio,Alessia Carboni,Giada Del Baldo et al.
Valentina Di Ruscio et al.
High-dose chemotherapy with autologous stem cell rescue has improved outcomes in patients with metastatic retinoblastoma (RB). However, significant short- and long-term toxicities-especially in very young children with a constitutional RB1 ...
Gustave Roussy immune score as an independent prognostic factor for treatment response and survival in advanced renal cell carcinoma treated with nivolumab in second-line and beyond [0.03%]
Gustave Roussy免疫评分作为晚期肾细胞癌接受纳武单抗二线或后线治疗的反应和生存的独立预后因素
Bülent Erdoğan,İvo Gökmen,Cagnur Elpen Kodaz et al.
Bülent Erdoğan et al.
Background: Metastatic renal cell carcinoma (mRCC) represents a significant challenge due to variable patient outcomes despite advancements in treatment. Nivolumab, a programmed death-1 (PD-1) inhibitor, has demonstrated ...